Becton Dickinson & Co SEC filings BDX
Becton Dickinson & Co has 1,003 filings in SEC EDGAR's recent list, going back to Feb 13, 2018. Its latest annual report, Form ARS, was filed on Dec 18, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Dec 18, 2025 | Sep 30, 2025 |
| 10-K | Annual report | Nov 25, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Dec 19, 2024 | Sep 30, 2024 |
| 10-K | Annual report | Nov 27, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Dec 14, 2023 | Sep 30, 2023 |
| 10-K | Annual report | Nov 21, 2023 | Sep 30, 2023 |
| 10-K | Annual report | Nov 22, 2022 | Sep 30, 2022 |
| 10-K | Annual report | Nov 24, 2021 | Sep 30, 2021 |
| 10-K | Annual report | Nov 25, 2020 | Sep 30, 2020 |
| 10-K | Annual report | Nov 27, 2019 | Sep 30, 2019 |
| 10-K | Annual report | Nov 21, 2018 | Sep 30, 2018 |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BDX (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NJ
- Headquarters
- Franklin Lakes, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 10795
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.